"CGIE (TM) is being built as future-facing infrastructure rather than a point solution," said Yusuf Henriques, Founder and CEO of IndyGeneUS Bio. "Our objective is to establish the AI×Bio Factory--the ...

In an era where precision medicine is redefining the foundations of healthcare, Sambasiva Rao Suura emerges as a pioneering force driving transformation at the intersection of artificial intelligence ...

BERLIN, GERMANY, September 2, 2025 /EINPresswire.com/ -- SeqOne, a pioneer in AI-driven genomic analysis, today announced it has entered into a definitive agreement ...

ARC Innovation at Sheba Medical Center, the Icahn School of Medicine at Mount Sinai, and NVIDIA are collaborating to leverage artificial intelligence for genomic discovery using large language model ...

Decision makers will want to realise the potential of AI for genomic medicine by speeding up delivery whilst minimising harms. We outline seven practical policy actions to help achieve this goal.

From data to deployment. Pipeline from single-base tokenization of >600 high-quality human ge-nomes into a MoE Transformer optimized for up to ~1 Mb context, and downstream use for embed-dings, ...

IndyGeneUS Bio today announced the filing of a patent application covering its Clinico-Genomic Insight Engine™ (CGIE™)—a foundational platform under development to support regulated whole-genome ...